A Success, but with Complications
But if he feels he needs the medication to function normally, I see no reason for the rest of us to object. I mean, we don't want to disincentivize someone's recovery, do we?
Select Page
by C. Scott McMillin | Mar 14, 2024 | Recovery | 0 |
But if he feels he needs the medication to function normally, I see no reason for the rest of us to object. I mean, we don't want to disincentivize someone's recovery, do we?
by C. Scott McMillin | Mar 4, 2024 | In the News | 0 |
by C. Scott McMillin | Feb 26, 2024 | In the News | 0 |
by C. Scott McMillin | Jan 18, 2024 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 15, 2024 | Treatment | 0 |
by C. Scott McMillin | Jan 8, 2024 | Addictive Substances | 0 |
by C. Scott McMillin | Dec 18, 2023 | Treatment | 0 |
Simply bringing up the possibility of ‘doing without’ could be immensely threatening.
Read Moreby C. Scott McMillin | Nov 16, 2023 | Public Policy | 0 |
When it comes to the availability of naloxone, the article states that “…while most states have decriminalized [opioid antagonists] … some, including Texas, continue to treat them as drug paraphernalia.”
Read Moreby C. Scott McMillin | Oct 30, 2023 | Addictive Substances | 0 |
Unfortunately, adulterating fentanyl with xylazine makes naloxone substantially less effective in terms of reviving an overdose victim.
Read Moreby C. Scott McMillin | Oct 26, 2023 | In the News | 0 |
But, his lawyer reminds us, we shouldn’t forget that his client is ‘only’ 25 years old. Not only that, the client reportedly has assured his attorney that “…I promise you, I’m not a bad person.”
Read Moreby C. Scott McMillin | Oct 16, 2023 | Addiction | 0 |
Extra naloxone doses were required to lift the victim out of a coma and lower the risk of respiratory arrest and death. Translation: New barriers to saving lives in the street. And more fatalities.
Read Moreby C. Scott McMillin | Sep 18, 2023 | In the News | 0 |
Yes, some of the corporations who helped fuel the opioid overdose epidemic will now be able to profit from selling us an important part of the solution
Read Moreby C. Scott McMillin | Aug 28, 2023 | In the News | 0 |
…it happened in Florida, and the original reporting was by Fox News.
Read Moreby C. Scott McMillin | Jul 27, 2023 | Addictive Substances | 0 |
…the research team said their finding “raises serious questions about the use of opioid therapy for acute low back and neck pain.” Such as, why risk it? If it isn’t effective, and for some, can make things worse.
Read Moreby C. Scott McMillin | Jun 22, 2023 | Treatment | 0 |
There appears to be good evidence for relying on an extended taper off opioids versus a more rapid process. Instead of fast cessation of use, the opioid is deliberately reduced on a preset schedule.
Read Moreby C. Scott McMillin | Apr 13, 2023 | Addictive Substances, In the News | 0 |
The President went on to insist that Mexican-made fentanyl pills only came in blue–
Read Moreby C. Scott McMillin | Apr 10, 2023 | Addictive Substances | 0 |
…since xylazine isn’t itself an opioid, the antagonist naloxone won’t reverse its effects. Even with prompt treatment, the user can still experience respiratory arrest.
Read Moreby C. Scott McMillin | Mar 27, 2023 | Thinking About Addiction | 0 |
…there are now some 300,000 Americans on methadone maintenance, and I’m assuming many of them will not want to transition to buprenorphine.
Read More